Related Experiment Video
Updated: Jun 12, 2026
09:48
Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
Published on: February 25, 2022
Pathogenesis of pituitary tumors
1Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Progress in Brain Research
|June 15, 2010
Summary
Pituitary tumors, often benign, arise from genetic and environmental factors. Understanding their initiation and growth is key to developing new treatments and models for these common neoplasms.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Pituitary tumors are common neoplasms, frequently benign, impacting hormone levels and nearby structures.
- Tumorigenesis involves oncogene activation (e.g., PTTG, HMGA2), tumor suppressor gene inactivation (e.g., MEN1, PRKAR1A), and epigenetic alterations.
- The tumor micro-environment, including steroid milieu and angiogenesis, facilitates pituitary tumor growth.
Purpose of the Study:
- To review the initiators and promoters of pituitary tumor pathogenesis.
- To explore the role of senescence in the benign nature of pituitary tumors.
- To suggest future research directions for understanding pituitary tumor development.
Main Methods:
- Literature review of genetic, epigenetic, and environmental factors in pituitary tumorigenesis.
- Analysis of the role of cellular senescence as a protective mechanism.
- Synthesis of current knowledge to propose future research strategies.
Main Results:
- Identified multiple initiators including genetic mutations and epigenetic changes.
- Highlighted the contribution of the micro-environment to tumor progression.
- Proposed senescence as a potential explanation for the benign behavior of some pituitary tumors.
Conclusions:
- Future research should employ systems approaches to unravel pituitary tumor pathogenesis.
- Investigating regulatory mechanisms of pituitary cell proliferation is crucial.
- Development of novel animal models and functional human cell lines is recommended for advancing pituitary tumor research.
Related Concept Videos
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:27Hormones of the Pituitary Gland
The small, pea-sized pituitary gland is located at the base of the brain. It is crucial in regulating various bodily functions, from growth to reproduction. The gland is divided into the anterior lobe and the posterior lobe. The secretory cell clusters in the pars distalis of the anterior pituitary lobe are controlled by hypothalamic regulators and synthesize six primary hormones.
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
01:17The Pituitary Gland
The pituitary is a small endocrine organ in the sphenoid bone under the hypothalamus. Primarily, the pituitary in adults has two distinct anatomical and functional regions— the anterior and posterior lobes. During human fetal development, a third pituitary gland region called the pars intermedia atrophies and disappears. However, some of its cells migrate and exist adjacent to the anterior pituitary in adults.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...